SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-17-003591
Filing Date
2017-06-12
Accepted
2017-06-12 17:01:04
Documents
2
Period of Report
2017-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formthree.html 3  
1 OWNERSHIP DOCUMENT formthree.xml 3 3622
2 EXHIBIT 24 exh_24.htm EX-24 7401
  Complete submission text file 0001171843-17-003591.txt   12399
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUCAMPO PHARMACEUTICALS 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address
Meyenburg Jason Patrick (Reporting) CIK: 0001709008 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33609 | Film No.: 17907180